1. Introduction
Ehlers–Danlos syndrome (EDS) encompasses a diverse group of inherited connective tissue disorders, each characterized by distinct genetic abnormalities affecting the synthesis and structure of collagen, a fundamental protein for the body’s connective tissues [
1,
2,
3,
4]. These disorders affect various types of collagen or the proteins that process them, leading to a wide spectrum of clinical manifestations. Among the diverse subtypes of EDS, vascular Ehlers–Danlos syndrome (vEDS) (phenotype MIM number 130050), historically known as type IV EDS, distinguishes itself as a particularly rare and potentially life-threatening condition [
3]. Its rarity is underscored by an estimated prevalence ranging from 1 in 10,000 to 1 in 150,000 individuals, accounting for approximately 4% of all EDS cases [
1,
3,
5,
6]. This subtype’s severity stems from its specific genetic origin: mutations within the COL3A1 gene (Gene/Locus MIM number 120180). This gene provides the blueprint for type III procollagen, a crucial building block of type III collagen, which is particularly abundant and vital in the structural integrity of blood vessel walls, the supporting framework of hollow organs (such as the intestines and uterus), and other critical connective tissues [
5,
6,
7,
8,
9]. The consequences of COL3A1 mutations are profound. Individuals with vEDS experience impaired production of normal type III procollagen, leading to the production of abnormal or insufficient amounts of this critical protein. This deficiency in properly formed type III collagen compromises the structural integrity and resilience of connective tissues throughout the body, resulting in the hallmark characteristic of significant tissue fragility. This fragility manifests most severely in the increased vulnerability of blood vessels to aneurysm formation, dissection, and rupture, as well as the increased risk of organ rupture, including the intestines, uterus, and spleen [
5,
6,
7,
8,
9]. This systemic weakness can also affect other connective tissues, contributing to joint hypermobility, skin translucency, and easy bruising, although these features are often less prominent than the vascular complications [
5,
6,
7,
8,
9];
Table 1.
The clinical presentation of vEDS is multifaceted. Cutaneous manifestations often include thin, translucent skin, a propensity for easy bruising, prominent superficial veins, and challenges with wound healing [
1,
7]. The most significant concern in vEDS lies in the potential for life-threatening vascular and gastrointestinal complications, such as arterial and venous aneurysms, arterial dissections, and spontaneous ruptures of vital organs, such as the colon and uterus [
1,
7]. Other clinical features may include joint hypermobility, musculoskeletal pain, delayed puberty, and a range of gastrointestinal complications [
1,
7].
Genetic counseling is crucial for families affected by vEDS because vEDS is an autosomal dominant condition. Genetic counseling provides families with information about the inheritance pattern, the risks of recurrence, and the options for genetic testing. It also allows families to discuss the implications of a vEDS diagnosis, including the potential for serious complications and the importance of ongoing medical management. Genetic counselors can provide emotional support and help families make informed decisions about family planning.
Intestinal complications represent a significant clinical challenge for individuals with vEDS. Spontaneous gastrointestinal perforation, primarily involving the colon, has been identified as a major digestive complication in this population [
2]. Importantly, these intestinal manifestations often serve as the initial presentation of this syndrome, typically occurring in adulthood [
2,
5]. Consequently, in pediatric patients presenting initially with gastrointestinal manifestations of vEDS but lacking a prior diagnosis, the level of clinical suspicion may be relatively low, potentially delaying appropriate diagnosis and increasing the risk of further complications.
Surgical procedures often lead to severe complications such as anastomotic leaks, fistulae, and peritonitis. These complications can rarely result in short bowel syndrome and the subsequent need for long-term parenteral nutrition (PN). Isolated cases of intestinal failure have been documented in the medical literature; their occurrence remains relatively infrequent, particularly within the pediatric population [
2,
5,
7,
11].
Intestinal failure in pediatric vEDS is a rarely reported complication, highlighting the need for further research and clinical experience sharing. This article details our institution’s management of two such cases through our specialized multidisciplinary intestinal rehabilitation program and presents a literature review of the few published reports.
3. Results
Two pediatric patients with vEDS and intestinal failure were included in the study. Both patients were male and of Latin/Caucasian ethnicity. The initial clinical presentation was at 4 and 13 years of age. Initially, both patients were treated at other hospitals for acute abdominal conditions but were subsequently referred to our institution for specialized management of surgical complications and intestinal failure. In both patients, there was no known family history of vEDS or related connective tissue disorders.
The first patient, a 13-year-old male, presented with suspected acute appendicitis and underwent an appendectomy at another hospital. Postoperatively, he developed spontaneous jejunal perforation, leading to emergency laparotomy and the creation of a jejunostomy. Three months later, an attempt was made to close the stoma. However, multiple postoperative complications ensued, including anastomotic leakage, spontaneous perforations of the ileum and duodenum, and the development of multiple enterocutaneous fistulae. These complications necessitated extensive intestinal resections, resulting in a jejunostomy performed at 80 cm distal to the duodeno-jejunal junction and dependence on long-term PN. No bleeding complications were observed. Although genetic testing was precluded by resource constraints, the patient’s distinctive facial features and extensive medical history strongly supported a clinical diagnosis of Ehlers–Danlos syndrome.
This patient fulfilled one major criterion (spontaneous intestinal perforation) and five minor criteria for vEDS, including thin and translucent skin, easy bruising, characteristic facial features, hypermobility of small joints, and tendon/muscle rupture (evident during postoperative recovery).
Eight years after diagnosis, a second episode of spontaneous duodenal perforation and fistula occurred. Management focused on wound care and fistula control using vacuum-assisted closure, and octreotyde was indicated, with a successful outcome. Despite surgical attempts, the patient’s family declined further interventions due to the high risk of complications. Eleven years after the initial diagnosis, the patient remains on home PN with a stable clinical course over the past three years. He has type 1 short bowel syndrome with a high-output proximal jejunostomy and a low-output second remaining enterocutaneous fistula.
The second patient, a 4-year-old male, was initially diagnosed with acute appendicitis. An appendectomy was performed. However, postoperatively, the patient developed complications, including a spontaneous perforation of the sigmoid colon. Subsequently, multiple jejunal perforations occurred, requiring several surgical interventions. To manage the complications and optimize enteral nutrition, a jejunostomy was created at 100 cm from the duodeno-jejunal junction. Clinical suspicion for vEDS arose during the postoperative course due to the unusual pattern of multiple bowel perforations. Subsequent genetic testing confirmed a mutation in the COL3A1 gene (c.1662 + 1G > A variant), confirming the molecular diagnosis of vEDS.
This patient met one major criterion (spontaneous intestinal perforation) and four minor criteria, including thin and translucent skin, easy bruising, characteristic facial features, and hypermobility of small joints.
After 18 months of multidisciplinary management of his short bowel syndrome within an intestinal rehabilitation program, a stoma closure procedure was scheduled. Technical modifications to the usual management in similar cases included delicate bowel handling maneuvers, a double-layer anastomosis, use of fibrin sealants, and the avoidance of fast-track postoperative management. No bleeding complications were observed;
Figure 1. Enteral autonomy was gradually re-established, and the patient was able to suspend PN.
Regarding the literature review, the initial database search using the terms “Ehlers-Danlos” AND (“intestinal failure” OR “short bowel” OR “parenteral nutrition”) yielded 11 articles (10 after duplicates removal). After screening titles and abstracts and reviewing full texts, four articles met the inclusion criteria for this review. Of these, two were case reports describing patients with vESD and IF. One case report described a 15-year-old patient, representing the only pediatric case identified in the literature [
7]. The other case report involved a 41-year-old patient [
10]. The remaining two articles were literature reviews that discussed cases of intestinal complications in vEDS, and these reviews referenced and mentioned the case reports described above, but did not report any new or additional cases [
2,
5]. Six articles were excluded for the following reasons: four articles focused on intestinal motility disorders in EDS, and two articles discussed anesthetic considerations in EDS. This review highlights the scarcity of pediatric data in the published literature regarding intestinal failure in EDS, with only one pediatric case identified.
4. Discussion
The cases presented describe two patients with severe gastrointestinal complications of vascular EDS requiring complex surgical interventions, leading to short bowel syndrome and intestinal failure. These cases provide an opportunity to review common and infrequent gastroenterological complications of vEDS and best practices when caring for these patients in the pediatric population, in the hope of improving the timely recognition and treatment of this rare disease.
The limited evidence base underscores the need for further research in this area. The reliance on case reports and the absence of larger studies represent significant limitations in the current understanding of this condition. The findings of this review will be discussed in relation to the cases presented in this study, exploring both similarities and any unique aspects observed.
While gastrointestinal complications are well-described in adults with vEDS, with 25% of index patients experiencing a first complication by the age of 20 years and over 80% by the age of 40 [
4], there remains a significant paucity of information regarding their presentation and management in the pediatric population. Importantly, gastrointestinal manifestations can be the initial clinical presentation of vEDS in some cases [
8]. Due to the rarity of the condition and the lack of specific early diagnostic markers, the diagnosis is frequently delayed [
5,
8]. Physicians, and especially surgeons, may lack critical information about the patient’s underlying connective tissue disorder. This can significantly impact decision-making, potentially leading to suboptimal treatment strategies and increased risks of complications due to the inherent tissue fragility associated with vEDS.
Although the diagnosis may be overlooked at initial presentation, certain clinical features should raise the suspicion of vEDS. These include typical facial characteristics, a family history of easy bruising, excessive joint laxity, vascular, uterine, or colonic rupture, and spontaneous pneumothorax [
5,
7,
8]. Also, when an intestinal perforation occurs without a clear cause, especially in young patients, the possibility of vEDS should be strongly considered [
2]. Spontaneous bowel perforations in young patients should raise concern for an underlying connective tissue disorder, such as vascular EDS, as this is a common first presentation (described in 21% of the patients) [
2,
6]. In our two patients, initial acute abdominal symptoms were assumed to be appendicitis, needing reintervention for poor clinical postoperative outcomes or surgical complications. This diagnosis delay motivated repeated operations with more tissue damage and the appearance of new intestinal lesions.
Surgeons and gastroenterologists who perform procedures on patients with vEDS must exercise extreme caution, minimizing tissue handling and manipulation due to the inherent tissue fragility [
8]. Specific intraoperative risks, such as the propensity for patients with EDS to bleed, cervical spine subluxation during endotracheal intubation, and the potential risk of arterial injury during surgery and central line insertion, should be carefully considered and discussed [
5]. Postoperative complications such as anastomotic leakage, enterocutaneous fistulas, stoma problems, severe intra-abdominal adhesions, wound dehiscence, infections, and incisional hernias are also common due to poor tissue quality [
5,
6,
8,
12].
Even though short bowel syndrome has been rarely reported in pediatric vEDS, its potential occurrence should be considered given the high risk of intestinal complications. Every surgical decision should prioritize minimizing the risk of bowel resection and the development of short bowel syndrome. Both of our cases presented with intestinal failure secondary to high-output stomas. Although the total remaining bowel length in the first case is unknown, and long enough in the second case, both of them remained dependent on PN for a long period of time, and the care received in the context of the multidisciplinary intestinal rehabilitation program warranted the avoidance of complications during the “waiting” period.
Management of colonic or intestinal perforations in vEDS remains challenging, with no consensus on the optimal surgical approach. Strategies employed include primary repair, primary repair with defunctioning stoma, Hartmann’s procedure, and total abdominal colectomy with either an end-ileostomy or ileorectal anastomosis [
2,
3,
5,
12]. Studies have shown higher rates of reperforation after partial colectomy with anastomosis compared to Hartmann’s procedure [
2,
5].
Some authors advocate for a more aggressive approach, suggesting that total abdominal colectomy with an end-ileostomy may be the safest option for patients with known vEDS to prevent further colonic perforation [
3,
8]. However, the leak rate of ileorectal anastomosis in this population can be as high as 50%, highlighting the significant risks associated with this approach [
5].
Successful outcomes have been reported using different surgical strategies. Duthie et al. described a successful case of laparoscopic management of colonic perforation in a pediatric patient [
5,
11]. This highlights the potential for minimally invasive approaches in select cases. Also, perioperative bleeding represents a significant concern in vEDS. Desmopressin use has been described by Mast et al. as a potential strategy for reducing perioperative bleeding in these patients [
13].
For wound healing and enterocutaneous fistulas, some authors recommend a trial of nonoperative conservative therapy, limiting surgical intervention to life-threatening situations. Still, 98% of the surgical procedures reported in this population are emergent surgeries [
5]. Elective surgeries such as stoma takedown should be approached with extreme caution and careful patient and family counseling due to the risk of repeat colonic perforation [
5,
8]. In the case we operated on, several meetings for discussion of potential risks with the patient and his family were needed before scheduling surgery.
It is crucial to acknowledge that the recommendations described above must be applied with extreme caution and careful consideration in pediatric patients with vEDS, as reported in the cases. In the first place, pediatric patients possess unique characteristics and risks that must be carefully distinguished from the adult population. Secondly, patients with intestinal failure, regardless of their underlying disease, are at significant risk for complications associated with long-term PN, including vascular thrombosis, catheter-related infections, and liver damage. In this context, surgeries aimed at improving intestinal continuity, such as ostomy closure and reconstruction of the gastrointestinal tract, can be fundamental to improving quality of life and reducing the long-term morbidity associated with PN dependence. In addition, optimizing nutritional status in the perioperative period may limit the contribution of malnutrition to poor outcomes [
11]. Therefore, the decision to avoid or postpone surgeries, or to resect the colon to prevent perforations, requires careful and individualized consideration in the pediatric population with intestinal failure. Balancing the risks and benefits of surgical intervention in this unique patient group is crucial.
Long-term management of patients with vEDS and IF demands a comprehensive, multidisciplinary approach involving a coordinated team of specialists, including gastroenterologists, surgeons, nutritionists, geneticists, and mental health professionals. A cornerstone of care for these patients, particularly those with short bowel syndrome, is nutritional support. PN becomes a necessity to ensure adequate caloric intake, macro- and micronutrient provision, and maintenance of growth and development. However, long-term PN carries its own set of risks, including catheter-related infections, central venous thrombosis, and liver complications. The use of semi-permanent vascular catheters, essential for PN delivery, may introduce a heightened risk of vascular complications in these already vulnerable patients. Given the inherent fragility of blood vessels in vEDS, the insertion and maintenance of these catheters require meticulous technique and vigilant monitoring for signs of thrombosis, infection, or other vascular compromise. Beyond nutritional support, ongoing surveillance for vEDS-related complications is paramount. This includes regular imaging studies to monitor for the development or progression of aneurysms or other vascular abnormalities. Given that these patients are already at increased risk for vascular events, the added stress of catheterizations and the potential for catheter-related complications further underscores the importance of careful monitoring and proactive management. Furthermore, the psychological impact of living with a chronic, life-threatening condition like vEDS, coupled with the challenges of managing intestinal failure and long-term PN, can be significant. Therefore, access to mental health support, including therapy and counseling, is essential to address anxiety, depression, and other emotional challenges. Finally, optimizing quality of life is a central goal. This involves not only managing physical symptoms but also supporting the patient’s social and emotional well-being. Regular follow-up with specialists, open communication between the medical team and the family, and a focus on individualized care are essential for achieving the best possible long-term outcomes for children and adults with vEDS and intestinal failure.
The present report has several limitations, mainly due to the small sample size. Although the review of the existing literature was not systematically performed, no significant published experience in children with vEDS and bowel complications with intestinal failure was found. The issues discussed above are only intended to give the reader more information, but should not be generalized to all patients.
5. Conclusions
This article presents two cases of pediatric patients with vEDS who developed intestinal failure and dependence on long-term PN, and the only other two cases reported in the literature so far. These cases underscore the significant challenges associated with managing gastrointestinal complications in this rare but potentially life-threatening condition.
In the pediatric population, the decision-making process regarding surgical interventions must be carefully individualized, considering the potential benefits and risks in the context of long-term outcomes. While aggressive surgical approaches, such as total colectomy, may be considered to prevent future perforations, the high rate of complications associated with these procedures, particularly in the pediatric population with intestinal failure, necessitates a cautious and individualized approach.
The management of pediatric patients with vEDS and intestinal failure requires a multidisciplinary approach involving pediatricians, surgeons, gastroenterologists, geneticists, and nutritionists. Early diagnosis and close monitoring are crucial for optimizing patient outcomes. Further research is needed to better understand the natural history of gastrointestinal complications in pediatric vEDS, develop evidence-based treatment guidelines, and improve long-term outcomes for these patients.